Biotechnology Portfolio Price To Book vs. One Year Return
| FBIOX Fund | USD 19.38 0.36 1.82% |
For Biotechnology Portfolio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biotechnology Portfolio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biotechnology Portfolio Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biotechnology Portfolio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biotechnology Portfolio Biotechnology over time as well as its relative position and ranking within its peers.
Biotechnology |
Biotechnology Portfolio One Year Return vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Portfolio's current stock value. Our valuation model uses many indicators to compare Biotechnology Portfolio value to that of its competitors to determine the firm's financial worth. Biotechnology Portfolio Biotechnology is one of the top funds in price to book among similar funds. It also is one of the top funds in one year return among similar funds reporting about 9.04 of One Year Return per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Portfolio's earnings, one of the primary drivers of an investment's value.Biotechnology One Year Return vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Biotechnology Portfolio |
| = | 3.43 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Biotechnology Portfolio |
| = | 31.00 % |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
Biotechnology One Year Return Comparison
Biotechnology Portfolio is currently under evaluation in one year return among similar funds.
Biotechnology Portfolio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biotechnology Portfolio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biotechnology Portfolio will eventually generate negative long term returns. The profitability progress is the general direction of Biotechnology Portfolio's change in net profit over the period of time. It can combine multiple indicators of Biotechnology Portfolio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuers financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
Biotechnology Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biotechnology Portfolio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biotechnology Portfolio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biotechnology Portfolio's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Biotechnology Portfolio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Use Investing Themes to Complement your Biotechnology Portfolio position
In addition to having Biotechnology Portfolio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Value Funds Thematic Idea Now
Small Value Funds
Funds or Etfs that invest in the undervalued stocks of small to mid-sized companies. The Small Value Funds theme has 31 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Value Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Biotechnology Mutual Fund
To fully project Biotechnology Portfolio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biotechnology Portfolio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biotechnology Portfolio's income statement, its balance sheet, and the statement of cash flows.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |